Sandra Feldt

1.0k total citations
11 papers, 863 citations indexed

About

Sandra Feldt is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Sandra Feldt has authored 11 papers receiving a total of 863 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cardiology and Cardiovascular Medicine, 5 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Molecular Biology. Recurrent topics in Sandra Feldt's work include Renin-Angiotensin System Studies (5 papers), Hormonal Regulation and Hypertension (4 papers) and Receptor Mechanisms and Signaling (3 papers). Sandra Feldt is often cited by papers focused on Renin-Angiotensin System Studies (5 papers), Hormonal Regulation and Hypertension (4 papers) and Receptor Mechanisms and Signaling (3 papers). Sandra Feldt collaborates with scholars based in Germany, United States and Switzerland. Sandra Feldt's co-authors include Friedrich C. Luft, Dominik N. Müller, Ralf Dechend, Ulrike Maschke, Aurélie Contrepas, A.H. Jan Danser, Geneviève Nguyen, Wieslawa Maniara, Maren Wellner and Xuan Hong and has published in prestigious journals such as Circulation, Hypertension and Journal of the American Society of Nephrology.

In The Last Decade

Sandra Feldt

11 papers receiving 845 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandra Feldt Germany 10 663 548 304 86 71 11 863
Minolfa C. Prieto‐Carrasquero United States 10 629 0.9× 528 1.0× 256 0.8× 108 1.3× 116 1.6× 20 880
Machiko Yabana Japan 18 549 0.8× 362 0.7× 314 1.0× 122 1.4× 46 0.6× 46 883
Fabiana Filigheddu Italy 14 353 0.5× 432 0.8× 198 0.7× 48 0.6× 68 1.0× 25 787
Despina Tsorotes Australia 12 249 0.4× 222 0.4× 333 1.1× 77 0.9× 92 1.3× 12 890
Tomoko Takemitsu Japan 13 1.3k 1.9× 918 1.7× 592 1.9× 121 1.4× 54 0.8× 19 1.5k
Toru Dejima Japan 15 397 0.6× 187 0.3× 127 0.4× 59 0.7× 53 0.7× 27 580
Stephen A. Katz United States 16 418 0.6× 237 0.4× 255 0.8× 48 0.6× 66 0.9× 47 905
Kazushi Uneda Japan 17 310 0.5× 288 0.5× 207 0.7× 111 1.3× 58 0.8× 58 802
Tomohiko Kanaoka Japan 17 345 0.5× 226 0.4× 142 0.5× 64 0.7× 50 0.7× 51 706
Zdeňka Vaňourková Czechia 17 508 0.8× 426 0.8× 100 0.3× 58 0.7× 38 0.5× 43 710

Countries citing papers authored by Sandra Feldt

Since Specialization
Citations

This map shows the geographic impact of Sandra Feldt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Feldt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Feldt more than expected).

Fields of papers citing papers by Sandra Feldt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Feldt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Feldt. The network helps show where Sandra Feldt may publish in the future.

Co-authorship network of co-authors of Sandra Feldt

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Feldt. A scholar is included among the top collaborators of Sandra Feldt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Feldt. Sandra Feldt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Schorr, Susanne Gabriele, Christiane Eickhoff, Sandra Feldt, Carina Hohmann, & Martin Schulz. (2014). Exploring the potential impact of hospital ward-based pharmacy interns on drug safety.. PubMed. 69(4). 316–20. 9 indexed citations
2.
Feldt, Sandra, et al.. (2012). Incidence of thyroid hormone therapy in patients treated with sunitinib or sorafenib: A cohort study. European Journal of Cancer. 48(7). 974–981. 29 indexed citations
3.
Quinzler, Renate, Sandra Feldt, Katrin Schüssel, et al.. (2011). Treatment duration (persistence) of basal insulin supported oral therapy (BOT) in Type-2 diabetic patients: comparison of insulin glargine with NPH insulin. International Journal of Clinical Pharmacology and Therapeutics. 50(1). 24–32. 9 indexed citations
4.
Quinzler, Renate, et al.. (2009). DB2 PERSISTENCE WITH BASAL SUPPORTED ORAL THERAPY—COMPARISON OF INSULIN GLARGINE VERSUS NPH INSULIN. Value in Health. 12(7). A234–A234. 1 indexed citations
5.
Feldt, Sandra, Ulrike Maschke, Ralf Dechend, Friedrich C. Luft, & Dominik N. Müller. (2008). The Putative (Pro)renin Receptor Blocker HRP Fails to Prevent (Pro)renin Signaling. Journal of the American Society of Nephrology. 19(4). 743–748. 122 indexed citations
6.
Gratze, Petra, Ralf Dechend, Joon-Keun Park, et al.. (2008). Novel Role for Inhibitor of Differentiation 2 in the Genesis of Angiotensin II–Induced Hypertension. Circulation. 117(20). 2645–2656. 29 indexed citations
7.
Müller, Dominik N., Bernd Klanke, Sandra Feldt, et al.. (2008). (Pro)Renin Receptor Peptide Inhibitor “Handle-Region” Peptide Does Not Affect Hypertensive Nephrosclerosis in Goldblatt Rats. Hypertension. 51(3). 676–681. 114 indexed citations
8.
Feldt, Sandra, Wendy W. Batenburg, István Mazák, et al.. (2008). Prorenin and Renin-Induced Extracellular Signal-Regulated Kinase 1/2 Activation in Monocytes Is Not Blocked by Aliskiren or the Handle-Region Peptide. Hypertension. 51(3). 682–688. 190 indexed citations
9.
Feldman, David L., 良樹 鷹津, Xuan Hong, et al.. (2008). Effects of Aliskiren on Blood Pressure, Albuminuria, and (Pro)Renin Receptor Expression in Diabetic TG(mRen-2)27 Rats. Hypertension. 52(1). 130–136. 240 indexed citations
10.
Park, Joon-Keun, Robert Fischer, Ralf Dechend, et al.. (2007). p38 Mitogen-Activated Protein Kinase Inhibition Ameliorates Angiotensin II–Induced Target Organ Damage. Hypertension. 49(3). 481–489. 49 indexed citations
11.
Fischer, Robert, Ralf Dechend, Fatimunnisa Qadri, et al.. (2007). Dietary n-3 Polyunsaturated Fatty Acids and Direct Renin Inhibition Improve Electrical Remodeling in a Model of High Human Renin Hypertension. Hypertension. 51(2). 540–546. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Minolfa C. Prieto‐Carrasquero Breakdown of academic impact, for papers by Machiko Yabana Breakdown of academic impact, for papers by Fabiana Filigheddu Breakdown of academic impact, for papers by Despina Tsorotes Breakdown of academic impact, for papers by Tomoko Takemitsu Breakdown of academic impact, for papers by Toru Dejima Breakdown of academic impact, for papers by Stephen A. Katz Breakdown of academic impact, for papers by Kazushi Uneda Breakdown of academic impact, for papers by Tomohiko Kanaoka Breakdown of academic impact, for papers by Zdeňka Vaňourková
Rankless by CCL
2026